Results 1 to 10 of about 5,278,927 (357)

Integrating Artificial Intelligence Tools in the Clinical Research Setting: The Ovarian Cancer Use Case

Diagnostics, 2023
Artificial intelligence (AI) methods applied to healthcare problems have shown enormous potential to alleviate the burden of health services worldwide and to improve the accuracy and reproducibility of predictions. In particular, developments in computer
Lorena Escudero Sanchez, Thomas Buddenkotte, Mohammad Al Sa’d, Cathal McCague, James Darcy, Leonardo Rundo, Alex Samoshkin, Martin J. Graves, Victoria Hollamby, Paul Browne, Mireia Crispin-Ortuzar, Ramona Woitek, Evis Sala, Carola-Bibiane Schönlieb, Simon J. Doran, Ozan Öktem   +15 more
doaj   +1 more source

Building capacity for clinical research in developing countries: the INDOX cancer research network experience [PDF]

Global Health Action, 2012
Transnational Organisations increasingly prioritise the need to support local research capacity in low and middle income countries in order that local priorities are addressed with due consideration of contextual issues. There remains limited evidence on
Raghib Ali, Alexander Finlayson, on behalf of the INDOX Cancer Research Network   +2 more
doaj   +1 more source

Women in contemporary cancer research [PDF]

, 2020
Despite recent advances, gender inequality persists in many scientific fields, including medicine. Thus far, no study has extensively analyzed the gender composition of contemporary researchers in the oncology field.
AACR—Women in Cancer Research (WICR), Association of American Medical Colleges, Persson OD, Roskovensky LB, United Nations Educational, Scientific and Cultural Organization (UNESCO), Vogel G   +5 more
core   +1 more source

Artificial Intelligence in Cancer Research: Trends, Challenges and Future Directions

Life, 2022
The World Health Organization (WHO), in their 2022 report, identified cancer as one of the leading causes of death, accounting for about 16% of deaths worldwide.
Anu Maria Sebastian, David Peter
doaj   +1 more source

Current opportunities to catalyze research in nutrition and cancer prevention – an interdisciplinary perspective

BMC Medicine, 2019
Cancer Research UK and Ludwig Cancer Research convened an inaugural international Cancer Prevention and Nutrition Conference in London on December 3–4, 2018.
The Cancer Research UK - Ludwig Cancer Research Nutrition and Cancer Prevention Collaborative Group
doaj   +1 more source

Comparison of factors influencing the willingness to donate biospecimens among guardians of children with cancer and adult cancer patients

Cancer Medicine, 2022
Background This study examined and compared the attitudes and willingness of guardians of children with cancer and adult cancer patients toward donating biospecimens and clinical data for cancer research.
Hongxiang Gao, Baige Cao, Nan Dang, Song Gu, Min Xu, Bin Ji, Yiqi Shi, Shijian Liu, Congrong Wang   +8 more
doaj   +1 more source

Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition) [PDF]

Zhongguo aizheng zazhi
Nausea and vomiting are common adverse reactions in tumor patients during anti-tumor therapy such as chemotherapy, radiotherapy, targeted therapy and immunotherapy.
Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association , Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association , Cancer Prevention and Clinical Research Committee of Chinese Aging Well Association
doaj   +1 more source

FI-Net: Identification of Cancer Driver Genes by Using Functional Impact Prediction Neural Network

Frontiers in Genetics, 2020
Identification of driver genes, whose mutations cause the development of tumors, is crucial for the improvement of cancer research and precision medicine.
Hong Gu, Xiaolu Xu, Pan Qin, Jia Wang
doaj   +1 more source

Cancer Outcomes Research [PDF]

Journal of the National Cancer Institute Monographs, 2004
If the central business of cancer outcomes research is the pursuit of information relevant to a range of decision makers (1), i.e., patients, families, providers, payers, regulators, standards setters, and researchers, several questions quickly arise. What is the nature and scientific quality of the information currently being produced?
Joseph, Lipscomb, Molla S, Donaldson, Neeraj K, Arora, Martin L, Brown, Steven B, Clauser, Arnold L, Potosky, Bryce B, Reeve, Julia H, Rowland, Claire F, Snyder, Stephen H, Taplin   +9 more
openaire   +2 more sources

Rosalind and Morris Goodman Cancer Research Centre Annual Symposium | May 6-7, 2021

McGill Journal of Medicine, 2021
n ...
The Rosalind and Morris Goodman Cancer Research Centre (GCRC)
doaj